Twist Bioscience Corp officer Paula Green filed a Form 144 notice of proposed sale on November 3, 2026, covering 1,007 shares of common stock acquired through a restricted stock vesting on November 2, 2026.

Key Highlights

  • Proposed sale: 1,007 shares of Twist Bioscience common stock with an aggregate market value of $136,349.51.
  • Acquisition: The 1,007 shares were acquired on November 2, 2026, through a restricted stock vesting from the issuer, classified as compensation.
  • Approximate sale date: November 3, 2026, through Fidelity Brokerage Services LLC.
  • Shares outstanding: 62,707,424 shares of common stock outstanding as reported in the filing.
  • Prior sales in past three months: Green sold a combined 13,782 shares in five separate transactions between August 3, 2026, and October 2, 2026, generating gross proceeds totaling $2,351,133.34.
  • Tax coverage noted: According to the filing's remarks, the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."

Green's Proposed Sale and Recent Transaction History at Twist Bioscience

The Form 144 was filed with the SEC on November 3, 2026, by Paula Green, identified as an officer of Twist Bioscience Corp (NASDAQ:TWST). The notice covers a proposed sale of 1,007 shares of common stock with a stated aggregate market value of $136,349.51. The shares were acquired one day earlier, on November 2, 2026, via restricted stock vesting directly from the issuer, with the nature of payment listed as compensation.

The filing disclosed five sales by Green in the three months preceding the notice. Those transactions occurred on August 3, 2026 (1,133 shares, $96,668.92), August 21, 2026 (1,360 shares, $189,130.30), September 8, 2026 (907 shares, $111,219.88), September 21, 2026 (294 shares, $48,654.47), and October 2, 2026 (10,088 shares, $1,905,459.77). Together, these five sales totaled 13,782 shares and gross proceeds of $2,351,133.34, according to the filing.

The filing's remarks section states that the proposed sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." The notice was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Paula Green. Twist Bioscience Corp is headquartered at 681 Gateway Blvd., South San Francisco, California 94080, and its SEC file number is listed as 001-38720.

What Was Disclosed

Twist Bioscience officer Paula Green filed a Form 144 on November 3, 2026, proposing to sell 1,007 shares acquired through restricted stock vesting, with the stated purpose of covering tax obligations related to the equity award settlement.